+ All Categories
Home > Documents > ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on...

ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on...

Date post: 23-Aug-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
16
14 th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease 8 - 10 March 2017 | Barcelona | Spain P R E L I M I N A R Y S C I E N T I F I C P R O G R A M
Transcript
Page 1: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

14th Annual ENETS Conference

for the Diagnosis and Treatment of

Neuroendocrine Tumor Disease

8 - 10 March 2017 | Barcelona | Spain

P R E L I M I N A R Y S C I E N T I F I C P R O G R A M

Page 2: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Table of Contents

Scientific Organizing Committee 4 ........................................................................................................

ENETS Scientific Conference Program 5 ................................................................................................

08.03.2017 5 .........................................................................................................................................

ENETS Postgraduate Course 5 ............................................................................................................... ENETS Annual Conference Welcome Reception 6 .................................................................................

09.03.2017 7 .........................................................................................................................................

ENETS/NANETS Young Investigator Symposium 7 ................................................................................. Meet the Professor 7 ............................................................................................................................. Nurse Workshop 8 ................................................................................................................................. Welcome 8 ............................................................................................................................................ Session 1: Lessons Learned from Other Cancers 8 ............................................................................... Coffee Break 8 ...................................................................................................................................... Session 2A: Tumorigenic Mechanisms of NET 8 .................................................................................... Session 2B: Medical Therapies and Goals 8 .......................................................................................... Session 3A: Aggressive NEN 9 ............................................................................................................... Session 3B: Interventional Radiology 9 ................................................................................................. Life Achievement Award 2017 9 ........................................................................................................... Satellite Symposium I, Industry - Sponsored 10 .................................................................................... Lunch Break 10 ..................................................................................................................................... Session 4A: Basic Science Abstracts 10 ................................................................................................ Session 4B: Clinical Abstracts 10 .......................................................................................................... Poster Session A 11 ............................................................................................................................... Poster Walks 11 .................................................................................................................................... Session 5: Multidisciplinary Session: Management of Resectable Liver Metastases 11 ........................ ENETS General Assembly (Members Only) 11 ....................................................................................... Satellite Symposium II, Industry - Sponsored 11 ...................................................................................

10.03.2017 12 .......................................................................................................................................

Satellite Symposium III, Industry - Sponsored 12 .................................................................................. Workshop: Imaging Update 12 .............................................................................................................. Session 6: How To Not Do Harm? Who Should Not Get: 12 ................................................................... Unmet Needs in NET Care and Research: Priorities for Actions-A Joint Symposium of INCA and ENETS

12 .......................................................................................................................................................... Session 7: ENETS Surgical Protocols 13 ................................................................................................ Poster Session B 13 ...............................................................................................................................

Page 3: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Table of Contents

Poster Walks 13 .................................................................................................................................... Session 8A: Nurse Symposium 13 ......................................................................................................... Session 8B: Response Prediction and Resistance 13 ............................................................................. Session 9A: Challenges and Controversies of Therapy 14 ..................................................................... Session 9B: Tumor Dynamics in Everyday Practice. Measuring Tumor Growth and Agressiveness ... 14Lunch Break 14 ..................................................................................................................................... Satellite Symposium IV, Industry - Sponsored 14 .................................................................................. Young Investigator (Presentation ENETS Grant Winners) 15 ................................................................. ENETS Grants and Awards Ceremony 2017 15 ..................................................................................... Session 10: What’s New in the Field? 15 ............................................................................................... Closing Comment 15 .............................................................................................................................

Contact info 16 ......................................................................................................................................

Page 4: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Organizing Committee 4

Martyn CaplinUnited Kingdom

Rocio Garcia-CarboneroSpain

Wouter W. de HerderNetherlands

Massimo FalconiItaly

Reza KianmaneshFrance

Dermot O'TooleIreland

Marianne Ellen PavelGermany

Aurel PerrenSwitzerland

Eva Tiensuu JansonSweden

Bertram WiedenmannGermany

Page 5: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Program 5

Wednesday, 08.03.2017

ENETS Postgraduate CourseTime: Wednesday 08:15 - 17:15Room: Meeting room 112Chairs: Christos Toumpanakis, GBR; Martyn Caplin, GBR; Rocio Garcia-Carbonero, ESP

08:15 - 09:15 Registration and Coffee

09:15 - 09:30 IntroductionMartyn Caplin, GBR

09:30 - 11:10 Postgraduate Course Part 1 – Chairs: Martyn Caplin, GBR; Aurel Perren, SUI

09:30 - 09:50 Pathology Overview & New Advances to Aid TherapyAurel Perren, SUI

09:50 - 10:10 Chromogranin A is Dead – Long Live the New Biomarkers!Christina Thirlwell, GBR

10:10 - 10:20 Discussion

10:20 - 10:40 Overview of Medical Management of Midgut NETs and ENETS GuidelinesDieter Hörsch, GER

10:40 - 11:00 Carcinoid Heart DiseaseJoseph Davar, GBR

11:00 - 11:10 Discussion

11:10 - 11:40 Coffee Break

11:40 - 13:10 Postgraduate Course Part 2 – Chairs: Wouter W. de Herder, NED; Rocio Garcia-Carbonero, ESP

11:40 - 11:48 Is There Still a Role for Interferon in NETs? - YesKjell Öberg, SWE

11:48 - 11:55 Is There Still a Role for Interferon in NETs? - NoMarc Peeters, BEL

11:55 - 12:00 Discussion

12:00 - 12:20 Overview of Medical Management of Pancreatic NETs and ENETS GuidelinesRocio Garcia-Carbonero, ESP

12:20 - 12:40 Advances in Endoscopic Ultrasound and Endotherapy for Pancreatic NETStephen Pereira, GBR

12:40 - 13:00 Case Studies: Lessons in GastrinomaRobert Jensen, USA

13:00 - 13:10 Discussion

13:10 - 14:10 Lunch

14:10 - 15:20 Postgraduate Course Part 3 – Chairs: Günter Krejs, GER; Christos Toumpanakis, GBR

14:10 - 14:30 Gastric NETs – Short Case StudiesChristos Toumpanakis, GBR

14:30 - 14:50 Rectal NETs – Short Case StudiesAndreas Pascher, GER

14:50 - 15:10 Nutrition for GEP NETs – What Support is Appropriate?Ulrich-Frank Pape, GER

15:10 - 15:20 Discussion

Page 6: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Program 6

15:20 - 15:50 Coffee Break

15:50 - 17:05 Postgraduate Course Part 4 – Chairs: Martyn Caplin, GBR; Jaroslaw Ćwikła, POL

15:50 - 16:15 Paraganaglioma and Phaeochromocytoma Case StudiesAshley Grossman, GBR

16:15 - 16:35 Nuclear Medicine Imaging – What Does the Future Hold?Damian Wild, SUI

16:35 - 16:55 Nuclear Medicine Therapy – What Does the Future Hold?Richard P. Baum, GER

16:55 - 17:05 Discussion

17:05 - 17:15 Summary and CloseMartyn Caplin, GBR

ENETS Annual Conference Welcome ReceptionTime: Wednesday 17:15 - 18:15Room: Foyer in front of room 112

Page 7: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Program 7

Thursday, 09.03.2017 Parallel Sessions ............................................................................................................

ENETS/NANETS Young InvestigatorSymposiumTime: Thursday 07:30 - 08:30Room: Meeting room 111Chairs: David Metz, USA; Massimo Falconi, ITA

07:30 - 07:40Next-Generation Sequencing (NGS) inPancreatic Neuroendocrine Tumors(panNETs): Defining Differentiation and GradeGeneticallyNitya Raj, USA

07:40 - 07:50A Prognostic Model for Pulmonary CarcinoidTumors Based on Large ChromosomalAlterationsKonstantinos Leventakos, USA

07:50 - 08:00GSK3: A Novel Therapeutic Target in NETs?Svenja Nölting, GER

08:00 - 08:10TSC22D1 Expression and Association withClinic-Pathological Features in BronchialCarcinoidsGiulia Bresciani, ITA

08:10 - 08:20Interactions between SSTR Modulation viaLanreotide and Molecular Targeted Therapiesin Sequential and Combination Approaches InVitroSebastian Krug, GER

08:20 - 08:30Questions & Answers

Meet the ProfessorTime: Thursday 07:30 - 08:30

Meeting room 124 Workshop 1: Pathology: What Modern Pathologists Need to Know for Digestiveand pNETsAnne Couvelard, FRAGünter Klöppel, GER

Meeting room 125 Workshop 2: Surgical Knowhow “Special Tricks”Alain Sauvanet, FRAThomas Steinmüller, GER

Meeting room 127 Workshop 3: Practical Approaches to “Genetics in NETs”Barbro Eriksson, SWERajesh Thakker, GBR

Page 8: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Program 8

Meeting room 128 Workshop 4: Entering Patients in NET Clinical TrialsEnrique Grande, ESPJuan Valle, GBR

Parallel Sessions ............................................................................................................ Nurse WorkshopTime: Thursday 07:30 - 08:30Room: Meeting room 129 & 130Chair: Kjerstin Skrede Mordal, NOR

07:30 - 08:30Reality in Practice – Gastro-IntestinalSymptoms and Quality of Life in Patients withNETElizabeth Quaglia, GBRLise Munk Plum, DEN

WelcomeTime: Thursday 08:30 - 08:40Room: Meeting room 113-116 (Plenary)

08:30 - 08:40 WelcomeMassimo Falconi, ITA

Session 1: Lessons Learned from Other CancersTime: Thursday 08:40 - 09:50Room: Meeting room 113-116 (Plenary)Chairs: Bertram Wiedenmann, GER; Rocio Garcia-Carbonero, ESP

08:40 - 09:00 Immune System and CancerMichal Lotem, ISR

09:00 - 09:20 Tumor Heterogeneity – What Can We Learn from Breast Cancer?Jan Dumanski, SWE

09:20 - 09:40 Immune System and Heterogeneity in Neuroendocrine TumorsMatthew Kulke, USA

09:40 - 09:50 Presidential Abstract: VHL Genotype is Associated with Pancreatic NeuroendocrineTumors (PNETs) Phenotype in Patients with Von Hippel-Lindau Disease (VHLD)Amit Tirosh, USA

Coffee BreakTime: Thursday 09:50 - 10:20Room: Exhibition area

Parallel Sessions ............................................................................................................ Session 2A: Tumorigenic Mechanisms ofNETTime: Thursday 10:20 - 11:20Room: Meeting room 111Chairs: Aurel Perren, SUI; Eva Tiensuu Janson, SWE

Session 2B: Medical Therapies and GoalsTime: Thursday 10:20 - 11:20Room: Meeting room 113-116 (Plenary)Chairs: Eric Raymond, FRA; Simona Glasberg, ISR

Page 9: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Program 9

10:20 - 10:35MicroRNAs Associated with Small BowelNeuroendocrine Tumors and their MetastasesLeandro Castellano, GBR

10:35 - 10:50News in Whole Genome AnalysisAldo Scarpa, ITA

10:50 - 11:05Epidrug - Induced Upregulation of FunctionalSomatostatin Type 2 ReceptorsLeo Hofland, NED

11:05 - 11:10Panel Discussion

11:10 - 11:20Presidential Abstract: Analysis of mTOR,CXCR4 and PD-1 Checkpoint Pathways inMerkel Cell Neuroendocrine Carcinomas:Correlations with Prognosis and Viral StatusJonathan Benhamou, FRA

10:20 - 10:35What’s New for Treatment of RefractoryCarcinoid Syndrome?Ivan Borbath, BEL

10:35 - 10:50When Can We Stop Targeted Therapy inPatients with SD?Nicola Fazio, ITA

10:50 - 11:05Whats New in Lung NET?Marianne Ellen Pavel, GER

11:05 - 11:10Panel Discussion

11:10 - 11:20Presidential Abstract: An Open-Label PhaseIb/II Study of Sulfatinib in Patients withAdvanced Neuroendocrine Tumors(NCT02267967)

Parallel Sessions ............................................................................................................ Session 3A: Aggressive NENTime: Thursday 11:20 - 12:20Room: Meeting room 113-116 (Plenary)Chairs: Chris Verslype, BEL; Eric Baudin, FRA

11:20 - 11:40Classification of NEN G3: News andChallengesAurel Perren, SUI

11:40 - 12:20Debate: Any Place for Surgery

11:40 - 11:55PROHalfdan Sørbye, NOR

11:55 - 12:10CONUlrich Peter Knigge, DEN

12:10 - 12:20Rebuttal Comments

Session 3B: Interventional RadiologyTime: Thursday 11:20 - 12:20Room: Meeting room 111Chairs: Barbro Eriksson, SWE; Detlef Bartsch, GER

11:20 - 11:35Radiology – Radioembolisation, Liver DirectedTherapiesMarnix G.E.H. Lam, NED

11:35 - 11:50New Devices and Approaches (RFA,Microwave, Electroporation)Alan Sag, TUR

11:50 - 12:05Ablative or Loco-Regional Therapy in Patientswith Single Growing Lesions in Diffuse LiverMetastasesThierry de Baère, FRA

12:05 - 12:10Panel Discussion

12:10 - 12:20Presidential Abstract: InternationalMulticenter Retrospective Study on theEfficacy and Toxicity of Radioembolization inNeuroendocrine Tumours with yttrium-90resin microspheresArthur Braat, NED

Life Achievement Award 2017Time: Thursday 12:20 - 12:45Room: Meeting room 113-116 (Plenary)

Page 10: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Program 10

Chair: Massimo Falconi, ITA

12:20 - 12:30 DedicationEva Tiensuu Janson, SWE

12:30 - 12:45 Recipient and Keynote PresentationKjell Öberg, SWE

Parallel Sessions ............................................................................................................ Satellite Symposium I, Industry -SponsoredTime: Thursday 12:45 - 14:15Room: Meeting room 112

Lunch BreakTime: Thursday 12:45 - 14:15Room: Exhibition area

Parallel Sessions ............................................................................................................ Session 4A: Basic Science AbstractsTime: Thursday 14:15 - 15:15Room: Meeting room 111Chairs: Guido Rindi, ITA; Staffan Welin, SWE

14:15 - 14:25Implication of Neuropilin-2 in the Progressionof Small Intestinal Neuroendocrine Tumors:Towards a Promising Therapeutic Target?Julien Bollard, FRA

14:25 - 14:35Whole-Exome Sequencing (WES) of Samplesfrom Patients (pts) Classified as ExceptionalResponders (ER) Versus Poor Responders(PO) to Targeted Therapies in PancreaticNeuroendocrine Tumours (pNETs)Jorge Barriuso, GBR

14:35 - 14:443D Primary Cell Culture: A New PromisingPreclinical Model for PancreaticNeuroendocrine Tumors (pNETs)Ilaria Marinoni, SUI

14:44 - 14:54Efficacy of Lanreotide (LAN), both Alone andin Combination with Targeted Therapies in aPreclinical Model of PancreaticNeuroendocrine Tumors (pNETs)Oriol Casanovas, ESP

14:54 - 15:03PD-L1 is Expressed in a Subset of PancreaticNeuroendocrine Tumors (pNET)Charalampos Saganas, SUI

15:03 - 15:07Feasibility and Implication of Routine NGSAnalysis in Neuroendocrine CarcinomasUlrich Peter Knigge, DEN

Session 4B: Clinical AbstractsTime: Thursday 14:15 - 15:15Room: Meeting room 113-116 (Plenary)Chairs: Beata Kos-Kudła, POL; Nicholas Simon Reed,GBR

14:15 - 14:25NETTER-1 Phase III Trial: Recent Findings onQuality of Life in Patients with MidgutNeuroendocrine TumorsJonathan Strosberg, USA

14:25 - 14:35Neuroendocrine Neoplasm Trends over 32Years in Queensland, AustraliaDavid Wyld, AUS

14:35 - 14:44Gastroenteropancreatic High-GradeNeuroendocrine Carcinomas: A SEERDatabase Analysis of 6291 CasesArvind Dasari, USA

14:44 - 14:54Incidence and Characteristics of Ileo-ColonicNeuroendocrine Tumours Identified in the UKBowel Cancer Screening ProgrammeRaj Srirajaskanthan, GBR

14:54 - 15:03Adherence to WHO2010 Guideline forDiagnosis of Neuroendocrine Carcinoma andPrognostic SignificanceWouter Zandee, NED

15:03 - 15:07Prognosis of Sporadic Resected Small (≤ 2cm) Nonfunctional Pancreatic NeuroendocrineNeoplasms: A Multi-Institutional StudySebastien Gaujoux, FRA

Page 11: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Program 11

15:07 - 15:11Establishment of the First Well-DifferentiatedIn Vivo Human Pancreatic NeuroendocrineTumor ModelJoerg Schrader, GER

15:11 - 15:15The Expression of IGF Signaling PathwayGenes is Frequently Elevated in PancreaticNeuroendocrine Tumors, but isDownregulated in MetastasesErnst-Jan Speel, NED

15:07 - 15:11FDG-PET is Superior to WHO Grading inPredicting Overall Survival of Patients withNeuroendocrine Tumors: A Prospective Studyof 172 PatientsAndreas Kjaer, DEN

15:11 - 15:15Pancreatic Neuroendocrine Tumors (pNETs): APopulation-Based Analysis of Epidemiologyand OutcomesGustavo Westin, USA

Parallel Sessions ............................................................................................................ Poster Session ATime: Thursday 15:15 - 16:45Room: Exhibition area

Poster WalksTime: Thursday 15:15 - 16:45Room: Poster area, Exhibition hall

Session 5: Multidisciplinary Session: Management of Resectable LiverMetastases

Time: Thursday 16:45 - 17:45Room: Meeting room 113-116 (Plenary)Chairs: Anja Rinke, GER; Diego Ferone, ITA

16:45 - 17:00 Case PresentationChristos Toumpanakis, GBR

17:00 - 17:10 Medical Specialists ViewSimona Glasberg, ISR

17:10 - 17:20 Radiologists ViewBernhard Gebauer, GER

17:20 - 17:30 Surgeons ViewAndrea Frilling, GBR

17:30 - 17:45 Panel Discussion

ENETS General Assembly (Members Only)Time: Thursday 17:45 - 18:45Room: Meeting room 111

Satellite Symposium II, Industry - SponsoredTime: Thursday 18:45 - 20:15Room: Meeting room 112

Page 12: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Program 12

Friday, 10.03.2017 Parallel Sessions ............................................................................................................

Satellite Symposium III, Industry -SponsoredTime: Friday 07:00 - 08:30Room: Meeting room 112

Workshop: Imaging UpdateTime: Friday 07:30 - 08:30Room: Meeting room 129 & 130Chairs: Marie-Pierre Vullierme, FRA; RezaKianmanesh, FRA

07:30 - 07:42Conventional: DWI, Primovist MRIValérie Vilgrain, FRA

07:42 - 07:54Radiological Response PredictionAnders Sundin, SWE

07:54 - 08:06Impact of Functional Imaging on Managementof NET - Where is it Really Needed?Rodney Hicks, AUS

08:06 - 08:18Endoscopic Imaging (Primary TumorIdentification), EUS for Small Rectal andGastric NETDermot O'Toole, IRL

08:18 - 08:30Open Discussion

Parallel Sessions ............................................................................................................ Session 6: How To Not Do Harm? WhoShould Not Get:Time: Friday 08:30 - 09:30Room: Meeting room 113-116 (Plenary)Chairs: Martyn Caplin, GBR; Philippe Ruszniewski,FRA

08:30 - 08:40Interventional RadiologyEric Baudin, FRA

08:40 - 08:50SurgeryStefano Partelli, ITA

08:50 - 09:00ChemotherapyJuan Valle, GBR

09:00 - 09:10Targeted TherapyJaume Capdevila, ESP

09:10 - 09:20PRRTLisa Bodei, USA

09:20 - 09:30Panel Discussion

Unmet Needs in NET Care and Research:Priorities for Actions-A Joint Symposiumof INCA and ENETSTime: Friday 08:30 - 09:45Room: Meeting room 111Chairs: Massimo Falconi, ITA; Ron Hollander, USA

08:30 - 08:40Opening and IntroductionMassimo Falconi, ITARon Hollander, USA

08:40 - 08:45International Neuroendocrine Cancer Alliance(INCA) – The Global Voice for NET PatientsTeodora Kolarova, BUL

08:45 - 08:55Unmet Needs from the Patients' PerspectiveSimone Leyden, AUS

08:55 - 09:05Unmet Needs from the Physicians'PerspectiveBertram Wiedenmann, GER

Page 13: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Program 13

09:05 - 09:45Panel Discussion – How Can We Collaborate toMake Progress on Unmet Needs?

09:05 - 09:45ModerationRon Hollander, USA

09:05 - 09:45PanelCatherine Bouvier, GBRDermot O'Toole, IRLGeorge Fisher, USARodney Hicks, AUSSugandha Dureja, INDYoshiyuki Majima, JPN

Session 7: ENETS Surgical ProtocolsTime: Friday 09:30 - 09:45Room: Meeting room 113-116 (Plenary)Chairs: Andreas Pascher, GER; Elisabeth Nieveenvan Dijkum, NED

09:30 - 09:35MEN 1 and the PancreasBruno Niederle, AUT

09:35 - 09:40Intestine: Resection of Primary IntestinalTumor Versus Conservative Care in Patientswith Unrespectable Liver MetastasesReza Kianmanesh, FRA

09:40 - 09:45Sub-2mc Pancreatic NETSMassimo Falconi, ITA

Parallel Sessions ............................................................................................................ Poster Session BTime: Friday 09:45 - 10:50Room: Exhibition area

Poster WalksTime: Friday 09:45 - 10:50Room: Poster area, Exhibition hall

Parallel Sessions ............................................................................................................ Session 8A: Nurse SymposiumTime: Friday 10:50 - 11:50Room: Meeting room 111Chairs: Martyn Caplin, GBR; Philippa Davies, GBR

10:50 - 10:55IntroductionPhilippa Davies, GBR

10:55 - 11:10UK Survey on the Use of Long-ActingSomatostatin Analogues in NETMichael Tadman, GBR

Session 8B: Response Prediction andResistanceTime: Friday 10:50 - 11:50Room: Meeting room 113-116 (Plenary)Chairs: Ashley Grossman, GBR; Kjell Öberg, SWE

10:50 - 11:00Basic PrincipalsOriol Casanovas, ESP

11:00 - 11:10Molecular PathologyJean-Yves Scoazec, FRA

Page 14: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Program 14

11:10 - 11:25Patient Satisfaction Regarding Home InjectionService for Somatostatin AnaloguesWanda Geilvoet, NED

11:25 - 11:40Small Bowel Bacterial Overgrowth in NETPatientsTara Whyand, GBR

11:40 - 11:45Panel: Questions and Answers

11:45 - 11:50Closing CommentsJenny Falkerby, SWE

11:10 - 11:20Metabolic Symbiosis, A Resistance MechanismElizabeth Allen, BEL

11:20 - 11:30Resistance in Anti-Angiogenic TherapyRuben Bill, SUI

11:30 - 11:40Functional ImagingRodney Hicks, AUS

11:40 - 11:45Panel Discussion

11:45 - 11:50Presidential Abstract: Tumour Size is not aReliable Criterion for Resection of Patientswith Non-Secreting PancreaticNeuroendocrine Tumours: Results of anInternational, Multi-Centre, Operative CohortLogan Mills, GBR

Parallel Sessions ............................................................................................................ Session 9A: Challenges andControversies of TherapyTime: Friday 11:50 - 12:50Room: Meeting room 113-116 (Plenary)Chairs: Halfdan Sørbye, NOR; Vera Gorbunova, RUS

11:50 - 12:08Over or Under Treating Appendiceal NET?Current Evidence in this FieldGregory Kaltsas, GRE

12:08 - 12:25Role of Minimal Invasive Procedures VersusOpen Surgical Resection Digestive Tract andPancreasDetlef Bartsch, GER

12:25 - 12:39Sequencing Therapy in Pancreatic NETJonathan Strosberg, USA

12:39 - 12:42Panel Discussion

12:42 - 12:50Presidential Presentation: Comparison ofLong Terms Outcomes after Resection ofHepatic and/or Peritoneal Metastasis fromNeuroendocrine TumorsLéonor Benhaim, FRA

Session 9B: Tumor Dynamics in EverydayPractice. Measuring Tumor Growth andAgressivenessTime: Friday 11:50 - 12:50Room: Meeting room 111Chairs: Frederico Costa, BRA; John Ramage, GBR

11:50 - 12:10Biology/PathologyGuido Rindi, ITA

12:10 - 12:20RadiologyClarisse Dromain, SUI

12:20 - 12:30ClinicianUlrich-Frank Pape, GER

12:30 - 12:40Functional Imaging: Pro/ConAndreas Kjaer, DEN

12:40 - 12:50Panel Discussion

Parallel Sessions ............................................................................................................ Lunch BreakTime: Friday 12:50 - 14:20Room: Exhibition area

Satellite Symposium IV, Industry -SponsoredTime: Friday 12:50 - 14:20

Page 15: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Scientific Program 15

Room: Meeting room 112

Young Investigator (Presentation ENETS Grant Winners)Time: Friday 14:20 - 14:45Room: Meeting room 113-116 (Plenary)Chair: Massimo Falconi, ITA

14:20 - 14:24 CoE Excellence Academy Fellowship 2016 - 1Elettra Merola, ITA

14:24 - 14:28 CoE Excellence Academy Fellowship 2016 - 2Mauro Cives, ITA

14:28 - 14:32 CoE Excellence Academy Fellowship 2015Henning Jann, GER

14:32 - 14:37 CoE Young Investigator Grant 2016Joakim Crona, SWE

14:37 - 14:41 CoE Young Investigator Grant 2015Jerome Cros, FRA

14:41 - 14:45 ENETS Translational Medicine Fellowship 2015Su-Chen Li, SWE

ENETS Grants and Awards Ceremony 2017Time: Friday 14:45 - 15:10Room: Meeting room 113-116 (Plenary)Chair: Massimo Falconi, ITA

Session 10: What’s New in the Field?Time: Friday 15:10 - 16:10Room: Meeting room 113-116 (Plenary)Chairs: Juan Manuel O'Connor, ARG; Ramon Salazar, ESP

15:10 - 15:30 What’s New in NET Understanding?James Yao, USA

15:30 - 15:50 What’s New in Biology / Pathology?Marco Volante, ITA

15:50 - 16:10 Overview of Best Clinical and Basic Science AbstractsRobert Jensen, USA

Closing CommentTime: Friday 16:10 - 16:20Room: Meeting room 113-116 (Plenary)

16:10 - 16:20 Closing CommentMassimo Falconi, ITA

Page 16: ENETS - European Neuroendocrine Tumor Society · NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors Jonathan Strosberg, USA

Contact info 16

ENETS Office

c/o Charité - Universitätsmedizin Berlin

Campus Virchow-Klinikum

Hepatology and Gastroenterology

Augustenburger Platz 1

D-13353 Berlin, Germany

Tel: +49 30 450 - 553 096 (Program Information)

Fax: +49 30 450 - 553 942

Website: www.enets.org

General Conference E-Mail: [email protected]

General Conference Information: http://www.enets.org/annual_enets_conference.html


Recommended